Loading provider…
Loading provider…
Gynecologic Oncology Physician in Los Angeles, CA
NPI: 1386649713Primary Employer
USC Care Medical Group, Inc
keckmedicine.org
HQ Phone
Get M.D. Lynda's Phone Numberphone_androidMobile
Get M.D. Lynda's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1991 - 2026
TX State Medical License
1990 - 2003

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology

American Board of Obstetrics and Gynecology
Gynecologic Oncology
University of Texas M D Anderson Cancer Center
Fellowship • Gynecologic Oncology
1989 - 1991
UMass Chan Medical School
umassmed.edu
Residency • Obstetrics and Gynecology
1984 - 1989
McGill University Faculty of Medicine
Medical School
Until 1984
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 69 | 133 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 44 | 131 |
| 3 | 99212Established patient outpatient visit, total time 10-19 minutes | 12 | 15 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 11 | 16 |
[Long-term outcome of surgical treatment of patients with esophageal cancer].
Authors: Miroshnikov, B I, Pavelets, K V, Marochkin, N E, Roman, L D, Shostka, K G, Shiriaev, Iu N
Journal: Vestn Khir Im I I Grek
Authors: Shurkus, V E, Roman, L D, Shurkus, E A
Journal: Vestn Khir Im I I Grek
Lymph node dissection in esophageal cancer
Authors: Miroshnikov Bi, Lynda D. Roman, Pavelets Kv, Shostka Kg, Burakov Vv
Publication Date: 1999-01
Lead Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: eribulin mesylate
Lead Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI), Brooklyn ImmunoTherapeutics, LLC
Intervention / Treatment: OTHER: Placebo, OTHER: Laboratory Biomarker Analysis, PROCEDURE: Therapeutic Conventional Surgery, DRUG: Cyclophosphamide, DRUG: Omeprazole, BIOLOGICAL: IRX-2, DIETARY_SUPPLEMENT: Multivitamin, DRUG: Indomethacin
Lead Sponsor: Kevelt AS
Collaborators: Pharmasyntez
Intervention / Treatment: DRUG: Sodium cridanimod